cepharanthine has been researched along with 1,1-diphenyl-2-picrylhydrazyl in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Akasu, M; Goto, S; Kogure, K; Ohiwa, C; Terada, H | 1 |
| Karki, R; Kim, DW; Paudel, KR | 1 |
2 other study(ies) available for cepharanthine and 1,1-diphenyl-2-picrylhydrazyl
| Article | Year |
|---|---|
Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pH-dependent radical scavenge activity.
Topics: Alkaloids; Amines; Animals; Antioxidants; Benzylisoquinolines; Bepridil; Biphenyl Compounds; Free Radical Scavengers; Hydrogen-Ion Concentration; Lipid Peroxidation; Male; Membrane Fluidity; Mitochondria, Liver; Picrates; Rats; Rats, Wistar | 1999 |
Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Becaplermin; Benzylisoquinolines; Biphenyl Compounds; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Humans; Iron; Lipid Peroxidation; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase Type II; Picrates; Proto-Oncogene Proteins c-sis; RAW 264.7 Cells | 2016 |